Treatment of benign biliary leaks with transhepatic placement of coated self-expanding metallic stents by Páramo, M, García-Barquín, P, Carrillo, M, Millor Muruzábal, M, Vivas, I, Bilbao, J.I

Get full text

New oncologic emergencies: What is there to know about inmunotherapy and its potential side effects? by Barquín-García, Arantzazu, Molina-Cerrillo, Javier, Garrido, Pilar, Garcia-Palos, Daniel, Carrato, Alfredo, Alonso-Gordoa, Teresa

Get full text

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma by Kang, Eun Young, Millstein, Joshua, Popovic, Gordana, Bolithon, Adelyn, Talhouk, Aline, Chiu, Derek S., Anglesio, Michael S., Leung, Betty, Tang, Katrina, Lambie, Neil, Pavanello, Marina, Da-anoy, Annalyn, Loverix, Liselore, Garcia-Donas, Jesus, Ruiz-Llorente, Sergio, Yagüe-Fernandez, Monica, Edwards, Robert P., Elishaev, Esther, Olawaiye, Alexander, Taylor, Sarah, du Bois, Andreas, Harter, Philipp, Høgdall, Claus K., Armasu, Sebastian M., Huang, Yajue, Vierkant, Robert A., Winham, Stacey J., Kommoss, Felix K. F., Cramer, Daniel W., Sasamoto, Naoko, van-Wagensveld, Lilian, Lycke, Maria, Mateoiu, Constantina, Joseph, Janine, Odunsi, Kunle, Tseng, Chiu-Chen, Pearce, Celeste L., Conrads, Thomas P., Hartmann, Arndt, Hein, Alexander, Jones, Michael E., Leung, Yee, Beckmann, Matthias W., Ruebner, Matthias, Terry, Kathryn L., El-Bahrawy, Mona A., Coulson, Penny, Etter, John L., LaVigne-Mager, Katherine, Andress, Juergen, Grube, Marcel, Fischer, Anna, Neudeck, Nina, Robertson, Greg, Farrell, Rhonda, Barlow, Ellen, Quinn, Carmel, Hettiaratchi, Anusha, Casablanca, Yovanni, Erber, Ramona, Stewart, Colin J. R., Tan, Adeline, Yu, Yu, Boros, Jessica, Brand, Alison H., Harnett, Paul R., Kennedy, Catherine J., Nevins, Nikilyn, Morgan, Terry, Fasching, Peter A., Vergote, Ignace, Swerdlow, Anthony J., Candido dos Reis, Francisco J., Neuhausen, Susan L., Barquin-Garcia, Arantzazu, Modugno, Francesmary, Moysich, Kirsten B., Crowe, Philip J., Hirasawa, Akira, Heitz, Florian, Karlan, Beth Y., Goode, Ellen L., Sinn, Peter, Horlings, Hugo M., Høgdall, Estrid, Sundfeldt, Karin, Kommoss, Stefan, Staebler, Annette, Wu, Anna H., Cohen, Paul A., Lee, Cheng-Han, Steed, Helen, Le, Nhu D., Gayther, Simon A., Pharoah, Paul D. P., Konecny, Gottfried, Cook, Linda S., Ramus, Susan J., Kelemen, Linda E., Köbel, Martin

Get full text

181P Establishment of primary prostate cancer patient-derived organoids to assess PARP inhibitors antitumor activity beyond synthetic lethality by Grazioso, T.P., Otta, R., Navarro, P., Garcia-Donas, J., Fernandez, E. Sevillano, Garcia, A. Barquin, Sánchez, J. Romero, Justo, J., Moreno, J.F. Rodriguez

Get full text

Survival impact of the management of medical and urological complications during treatment with 1st line abiraterone (A) or enzalutamide (E) in patients with metastatic castration-... by Serrano Domingo, J.J., Lorca Alvaro, J., Avarez Rodriguez, S., Gajate Borau, P., Alonso Gordoa, T., Barquin Garcia, A., Molina, J., Martinez-Saez, O., Martin Huertas, R., Corral De La Fuente, E., Rodriguez-Patrón, R., Burgos Revilla, F.J., Carrato Mena, A.

Get full text

P058 - Survival impact of the management of medical and urological complications during treatment with 1st line abiraterone (A) or enzalutamide (E) in patients with metastatic cast... by Serrano Domingo, J.J., Lorca Alvaro, J., Avarez Rodriguez, S., Gajate Borau, P., Alonso Gordoa, T., Barquin Garcia, A., Molina, J., Martinez-Saez, O., Martin Huertas, R., Corral De La Fuente, E., Rodriguez-Patrón, R., Burgos Revilla, F.J., Carrato Mena, A.

Get full text